Statistical analyses Statistical analyses were performed using SAS 9.13 (SAS Institute, Cary, NC)
BPC-157 is not FDA-approved for any medical condition and is not a controlled substance
Here's an overview of the safety profile based on available evidence: Minimal Toxicity Minimal Toxicity Studies conducted prior to clinical trials have consistently found that BPC-157 has low toxicity when administered, with even high doses being well-tolerated by animals and showing no significant negative effects
No phone calls, no faxes, no separate pharmacy portals
Key Benefits: Promotes muscle and connective tissue repair Reduces fibrosis and scar formation in injuries Improves flexibility and range of motion Supports the formation of new blood vessels in healing tissues Who Is This For
Levels fall about 60% between age 20 and 60, which is a big part of why skin thins and heals slower over time